As of April 2024 Ampio Pharmaceuticals has a market cap of $0.39 Million. This makes Ampio Pharmaceuticals the world's 8361th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.39 M | -76.7% |
2023 | $1.7 M | -49.79% |
2022 | $3.39 M | -97.38% |
2021 | $0.12 B | -56% |
2020 | $0.29 B | 218.13% |
2019 | $92.48 M | 111.17% |
2018 | $43.79 M | -85.83% |
2017 | $0.30 B | 500.47% |
2016 | $51.47 M | -71.72% |
2015 | $0.18 B | 2.09% |
2014 | $0.17 B | -40.56% |
2013 | $0.29 B | 125.74% |
2012 | $0.13 B | 8.02% |
2011 | $0.12 B | 199.58% |
2010 | $41.05 M | 2844.04% |
2009 | $1.39 M | 0% |
2008 | $1.39 M |
On Apr 24th, 2024 the market cap of Ampio Pharmaceuticals was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $353.80 B | 89,034,951.83% | ๐บ๐ธ USA |
Pfizer PFE | $143.03 B | 35,994,967.80% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $185.42 B | 46,661,332.11% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $97.76 B | 24,601,994.77% | ๐บ๐ธ USA |
Rigel Pharmaceuticals RIGL | $0.19 B | 48,454.89% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | $0.45 B | 115,390.41% | ๐บ๐ธ USA |
Aerie Pharmaceuticals AERI | $0.75 B | 189,547.93% | ๐บ๐ธ USA |